Approval is a form of permission that tells young people this is acceptable.
In a decision that reframes an old danger in new packaging, the FDA has authorized ZYN nicotine pouches to be marketed as a reduced-harm alternative to cigarettes — a regulatory judgment that child psychologist Bonnie Halpern-Felsher fears misses the deeper question entirely. The pouches are discreet, odorless, and carry the implicit credibility of federal approval, making them uniquely suited to slip past the social guardrails that decades of tobacco control painstakingly erected. What is at stake is not merely one product's safety profile, but whether a generation of adolescents — whose developing brains are especially vulnerable to nicotine's grip — will inherit a new addiction crisis dressed in the language of harm reduction.
- The FDA's approval gives ZYN a credential no cigarette ever had — a government-endorsed 'safer' label that could make nicotine feel routine, even responsible, to young users.
- The pouches are nearly invisible in daily life: no smoke, no smell, no cough — a teenager can use one in a classroom or at the dinner table without detection.
- Child psychologist Bonnie Halpern-Felsher warns that the adolescent brain, still forming its impulse-control and reward circuitry, is precisely the target nicotine exploits most effectively.
- Decades of hard-won cultural consensus — that nicotine is risky and uncool — now faces erosion from a product that looks like a breath mint and carries a federal seal of relative safety.
- Public health advocates, educators, and parents are racing to respond, but the marketing has already launched and the normalization may already be underway.
The FDA has authorized ZYN nicotine pouches to be marketed as a safer alternative to cigarettes — a decision that regulatory logic can defend, but that child development researchers view with deep unease. The pouches are small, dissolvable, and leave no trace: no smell, no smoke, no visible sign. To a teenager, they resemble candy. To a parent, they might register as nothing at all.
Bonnie Halpern-Felsher, a child psychologist who studies adolescent health behavior, is not disputing the narrow comparison the FDA made. Combusted tobacco is genuinely more chemically destructive than a nicotine pouch. Her concern runs elsewhere: what happens when nicotine — one of the most addictive substances known — becomes normalized, accessible, and effectively invisible to the adults positioned to intervene?
The adolescent brain is still developing in the regions that govern impulse control and reward. Nicotine exposure during these years can reshape that development permanently, cementing addiction before a young person has the neurological capacity to recognize the pattern. The pouches require no inhalation, trigger no cough, and announce themselves to no one. The barrier to use was already low; federal harm-reduction approval lowers it further.
What Halpern-Felsher fears most is the cumulative logic of the approval itself. When a federal agency designates a product as less harmful, it sends a cultural signal — one that marketing amplifies, peer networks accelerate, and familiarity eventually normalizes. Young people who would never consider a cigarette may see a pouch as categorically different: something the government itself has deemed acceptable.
Decades of tobacco control work built a fragile cultural consensus that smoking was dangerous and socially undesirable. A nicotine product that sidesteps every visual and social cue associated with traditional smoking threatens to quietly dismantle that consensus. The real question now is whether parents, educators, and public health officials can move fast enough to counter a signal that is already in circulation — or whether the FDA's approval becomes the opening chapter of an addiction crisis that looks nothing like the one before it.
The Food and Drug Administration has taken a step that troubles child development experts: it now permits ZYN nicotine pouches to be marketed as a safer alternative to cigarettes. The regulatory green light opens a door that public health researchers worry will lead directly to young people's medicine cabinets and backpacks.
Bonnie Halpern-Felsher, a child psychologist who studies adolescent health behavior, sees the approval as a potential turning point in how an entire generation relates to nicotine. The pouches—small, discreet packets that dissolve between the gum and lip—carry none of the social stigma of cigarettes. They leave no smell, no visible smoke, no telltale ash. To a teenager, they look like candy or breath mints. To a parent, they might look like nothing at all.
The FDA's decision rests on a specific claim: that ZYN and similar products pose less risk than smoking. That narrower comparison is technically defensible. Combusted tobacco does deliver thousands of chemicals, many of them carcinogenic. A nicotine pouch delivers nicotine without the burn. But Halpern-Felsher's concern operates on a different plane. She is not comparing pouches to cigarettes. She is asking what happens when nicotine—a highly addictive substance—becomes normalized, accessible, and invisible to the adults who might otherwise intervene.
The adolescent brain is still developing, particularly in regions governing impulse control and reward processing. Nicotine exposure during these years can alter the trajectory of that development. It can cement patterns of addiction before a young person has the neurological equipment to recognize what is happening. The pouches do not require inhalation, do not trigger the cough reflex, do not announce themselves. A teenager can use one in a classroom, in a car, at dinner. The barrier to use—already low for a product marketed as harm-reduced—drops further still.
What worries Halpern-Felsher most is not the immediate health effect of a single pouch. It is the cumulative logic of the approval itself. When a federal agency stamps a product as less harmful, it sends a signal that the product is acceptable, manageable, perhaps even wise. Marketing language follows. Distribution widens. Peer adoption accelerates. The pouches become ordinary. By the time parents and educators recognize the trend, the normalization is already underway.
The broader context matters here. Decades of tobacco control work—restrictions on advertising, age limits on purchase, public education campaigns—created a cultural consensus that smoking was risky and uncool. That consensus is fragile. It depends on sustained messaging and consistent enforcement. A new nicotine delivery system that sidesteps the visual and social cues associated with traditional smoking threatens to unravel that work. Young people who would never touch a cigarette might see a pouch as fundamentally different, safer, a product the government itself has deemed acceptable.
Halpern-Felsher's warning is not that ZYN will instantly addict millions of teenagers. It is that the FDA's approval creates conditions under which that outcome becomes more likely. The pouches will find their way into schools. They will be shared among friends. They will be purchased online by minors. And each use will carry the implicit endorsement of a federal agency, a credential that no cigarette company could ever claim.
The question now is whether public health officials, educators, and parents can move quickly enough to counter that signal. The approval is already in place. The marketing has already begun. The real test will be whether the next generation of nicotine users can be prevented—or whether the FDA's decision to permit harm-reduction marketing becomes the opening chapter of a new addiction crisis, one that looks nothing like the last one.
Notable Quotes
The approval creates conditions under which youth nicotine addiction becomes more likely, not less— Bonnie Halpern-Felsher, child psychologist
The Hearth Conversation Another angle on the story
Why does the FDA's approval of ZYN as "less harmful" worry you more than the product itself?
Because approval is a form of permission. It tells young people and their parents that this is acceptable. That's more powerful than any marketing slogan.
But isn't it true that pouches are less harmful than cigarettes?
In isolation, yes. But we're not living in isolation. We're living in a world where teenagers are still developing their brains, where addiction is real, and where "less harmful" can become a gateway to dependence.
So you're saying the approval itself is the problem?
The approval is the problem because it normalizes nicotine use in a form that's invisible, accessible, and easy to hide. It undoes years of work making smoking uncool.
What happens if we do nothing?
We watch nicotine pouches become as common in schools as vaping was five years ago. Except this time, the government said it was okay.
Can that be reversed?
Only if we act now—education, enforcement, clear messaging that approval doesn't mean safe for young people. But the window is closing fast.